'The course provided excellent grounding in trial design and covered essential elements including the rationale for include those elements,' Amanda - QCTN's Clinical Trials Design (for Researchers) Course Attendee.
'I would like to thank QCTN for the lunch/seminar (Dr. Steve Arlington Luncheon) on Friday - it was much appreciated. I found the speaker very interesting and challenging. In addition, as I represent a small biotech start-up and as my background is in the food industry, I was/am in desperate need of a new network of contacts and your forum presented me an excellent opportunity to meet new people. I have come away with a host of contacts that I will be following up with this week,' David - Dr. Steve Arlington Presentation Luncheon Attendee.
'I have just received the lovely photos from Mario and consider myself lucky to be a part of the successful QCTN / Queensland trade mission to BioJapan,' Dr Suzanne Elliott - Operations Manager, Q-Pharm.
'In our business we are members of many professional organisations and I can say with confidence that QCTN out service any professional body that I have come in contact with. QCTN facilitates access to high level global networking events, professionally channel good solid leads, and take a personal interest in the success of your individual business. QCTN has grasped in a short period what most professional bodies don't get in a lifetime,' Deirdre Perkins - CEO, Perkins Resources.
'Thank you for the excellent job that you are doing as the CEO of QCTN and for making our trip to BioJapan most productive and enjoyable last week. Hopefully, some of the leads will turn into jobs for one or more of the team,' Professor Maree Smith - Executive Director, TetraQ.
QCTN has provided invaluable support and assistance to WRI in regard to the promotion of our services to the local, national and international clinical trials community. Our services are now being actively promoted worldwide which is something we could never have done on our own. I also firmly believe that 'all together' we, the members, have a far more significant and credible offering to the industry than if we were still trying to go-it-alone,' Vincent McFarlane - General Manager, The Wesley Research Institute.
'A very practical, easy-to-follow guide to research,' Sally - QCTN's Clinical Trials Design (for Researchers) Course Attendee.
'Well organised event and an engaging speaker that provided some thought-provoking statistics on where our industry might be headed. Great networking opportunities afterwards,' James Cameron - Senior Associate, McCullough Robertson Lawyers - Dr. Steve Arlington Presentation Luncheon Attendee.
'It is much appreciated and great to see how well you guys promote your members,' James Cameron - Senior Associate, McCullough Robertson - Lawyers.
'On behalf of Queensland Government Japan Offices, I thank you for giving me and my team an opportunity to work with you. It was lots of fun and I believe we have successfully achieved our mission of further raising the profile of Queensland clinical trial capabilities in Japan. We look forward to working with you to follow up on the leads from last week,' Tak Adachi - Commissioner QGTIO Japan.
'I would like to commend you on your daily newsletter which provides me with relevant and up to date information on developments in clinical trials, drug development and other areas of biotechnology. This has benefited me greatly, not only increasing my knowledge in these areas, but also in understanding the issues which face my clients in this area and allow me to negotiate appropriate insurance coverage for their businesses,' Paul Kelly - R J Neville & Associates.
I would like to thank QCTN for the opportunity to attend the DIA in Atlanta this year. The industry knowledge gained from attending the DIA coupled with the extensive networking opportunities resulted in trial opportunities within one week of returning from the conference. We will definitely be attending the conference annually, as this has been the most successful business development tool we have utilised,' Aletha Ward - General Manager, Sunnybank Research Centre.
'The recent lunch and presentation of PWC's forecast of the future for the Pharmaceutical industry to 2020 was extremely worthwhile. Sometimes in the middle of the busi-ness of business, you can lose sight of the overall aim of your day to day work and the future of healthcare. Steve Arlington reminded me of many important issues to consider - some opinions were controversial but the challenge to think about the future was invaluable. The venue, meal and networking opportunity were of a high standard. Thanks for facilitating this interesting presentation,' Gabrielle McKee - Associate Director Clinical Operations, Clinical Network Services (CNS) - Dr. Steve Arlilngton Presentation Luncheon.
'I found this presentation very insightful -- it was delivered with a systematic approach and the speaker had obvious extensive international experiences to draw on -- he was quite "passionate" about the talk as well -- good to see! Congratulations Mario and QCTN for sponsoring a very thoughtful presentation,' Trevor Neville - TranZition - Dr. Steve Arlington Presentation Luncheon Attendee.
'I enjoyed the time at AusBiotech and got several promising business leads. Money well spent!' Paul Salm - Director, Australian Bioanalytical Services Pty Ltd.
'I found the conference (AusBiotech 2007) a wonderful networking source. I have since received three new requirements (job vacancies) and made contact with nearly a dozen new potential clients which I am confident to say would never have happened had I not attended but more importantly I would not have received nearly as much exposure had I not been exhibiting on the QCTN/Queensland Government stand. Thank you very much for providing such a professional outfit which drew potential clients to the stand and I will recommend that DAA (Daryl Alexander & Associates) is an exhibiting member of the QCTN anywhere that I feel we will gain such great benefit and exposure,' Adam Stephen - Associate, Daryl Alexander & Associates.
Thank you Mario for mentioning our name to ICON - as a result they have forwarded a feasibility to us regarding the study,' Helen Woodhouse - Clinical Research Co-ordinator, The Wesley Research Institute.
